Ez-ADiCon: A Novel Glyco-remodeling Based Strategy That Enables Preparation of Homogenous Antibody-drug Conjugates Via One-step Enzymatic Transglycosylation with Payload-preloaded Bi-antennary Glycan Complexes
Overview
Authors
Affiliations
The conserved N-linked glycan at the Fc domain of recombinant monoclonal antibodies is an attractive target for site-specific payload conjugation for preparation of homogenous antibody-drug conjugates (ADCs). Here, we report a novel ADC constructing strategy, named "ez-ADiCon", that is achieved by one-step enzymatic transglycosylation of a payload-preloaded bi-antennary glycan oxazoline onto a deglycosylated antibody. In this method, a mixture of different glycoforms of the Fc-glycan is replaced with a pre-defined payload-linked glycan. Since two payloads are linked on each donor glycan substrate, efficient conjugation results in a highly homogenous ADC with mostly-four drug molecules per antibody, facilitating hydrophobic interaction chromatography analysis and purification. We validated this conjugation strategy using Monomethyl auristatin E (MMAE) and an anti-Human epidermal growth factor receptor 2 (anti-Her2) antibody as the model ADC components and demonstrated its target-specific in vitro cytotoxicity. Our novel conjugation strategy, ez-ADiCon, provides a new approach for the preparation of next generation ADCs.
Shivatare V, Huang H, Tseng T, Chuang P, Zeng Y, Wong C Isr J Chem. 2024; 63(10-11).
PMID: 38348405 PMC: 10861153. DOI: 10.1002/ijch.202300042.
Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directions.
Kumari S, Raj S, Babu M, Bhatti G, Bhatti J Arch Pharm Res. 2023; 47(1):40-65.
PMID: 38153656 DOI: 10.1007/s12272-023-01479-6.